Banner Portal
Analgesic choice in dentistry Part II : The toxicity
Remote

Keywords

Analgesics. Toxicity. Dentistry

How to Cite

1.
Pinheiro MLP, Branco FP, Volpato MC, Andrade ED. Analgesic choice in dentistry Part II : The toxicity. Braz. J. Oral Sci. [Internet]. 2015 Nov. 19 [cited 2024 Apr. 27];4(15):880-3. Available from: https://periodicos.sbu.unicamp.br/ojs/index.php/bjos/article/view/8641849

Abstract

Nonopioid analgesics are widely prescribed in dentistry. The first article of this series reviewed the mechanism of action of acetylsalicylic acid (aspirin), acetaminophen (paracetamol) and dipyrone; this part discusses the risks related to the use of these drugs. Paracetamol and dipyrone in therapeutic doses, unlike aspirin, do not cause nausea, do not interfere with protrombin time, do not inhibit the platelet aggregation, and do not produce as many side effects as does aspirin. The adverse reactions in relation to paracetamol seem to be restricted to situations where acute overdosage occurs. In relation to dipyrone, blood dyscrasias such as the agranulocytosis are the main adverse reactions.
https://doi.org/10.20396/bjos.v4i15.8641849
Remote

References

Alonzo HGA, Corrêa CL, Zambrone FAD. Analgésicos, antipiréticos e antiinflamatórios não esteroidais: dados epidemiológicos em seis centros de controle de intoxicações no Brasil. Rev Bras Toxicol. 2001; 14: 49-54.

Katzung BG, Trevor AJ. Nonsteridal anti-inflamatory drugs, nonopioid analgesics, e drugs used in gout. pharmacology. examination & board review. 3rd ed. East Norwalk: Appleton & Lange; 1993.

Vane JR, Botting RM. New insights into the mode of action of anti-inflammatory drugs. Inflamm Res. 1995; 44: 1-10.

Cooper AS, Desjardins PJ. Peripherally acting (nonopioid) analgesics. In: Neidle EA, Yagiela JA. Pharmacology and therapeutics for dentistry. 3rd ed. Saint Lowis: Mosby; 1989. p.293-307.

Yagiela JA, Neidle EA, Dowd FJ. Farmacologia e terapêutica para dentistas.4. ed. Guanabara Koogan: Rio de Janeiro; 2000.

Bobbio A, Bobbio SA. Indicações e limites da prescrição na gravidez. Rev Paul Odontol. 1979; 1: 10-9.

Delzer DD, Provant-Jr DD. Pregnancy and size effects of analgesics. Gen Dent. 1981; 29Wormald DL. Drogas y embarazo. Rev Chil Obstet Ginecol. 1991; 56: 293-300.

Miller MC. The pregnant dental patient. J Calif Dent Assoc. 1995; 23: 63-70.

Insel PA. Analgesic-antipyretic and anti-inflammatory agents and drugs employed in the treatment of gout. In: Goodman and Gilman’s the pharmacological basis of therapeutics. 9th ed. New York: Mc Graw Hill; 1996. p.617-57.

Grattan CE. Aspirin sensitivity and urticaria. Clin Exp Dermatol. 2003; 28: 123-7.

Sullivan-Bolyai JZ, Corey L. Epidemiology of Reye’s Syndrome. Epidemiol Rev. 1981; 3: 1-26.

Lane JE, Belson MG, Brown DK, Scheetz A. Chronic acetaminophen toxicity: a care report review of the literature. J Emerg Med. 2002; 23: 253-6.

Smilkstein MJ, Knapp Gl, Kulig KW, Rumack BH. Efficacy of oral N-acetilcysteine in the treatment of acetaminophen overdose. Analyses of the national multicenter study (1976 to 1985). N Engl J Med. 1988; 319: 1557-62.

Payan DG, Katzung BG. Nonsteroidal anti-inflammatory drugs; Nonopioid analgesics; Drugs used in gout. In: Katzung BG. Basic & clinical pharmacology. 6th ed. East Norwalk: Appleton & Lange; 1995. p.552.

Grahan GG, Scott KF, Day RO. Tolerability of paracetamol. Drugs. 2003; 63: 43-6. Thomas SH. Paracetamol (acetaminophen) poisoning. Pharmacol Ther. 1993; 60: 91-120.

Lüllmann H, Mohr K. Farmacologia – texto e atlas. 4. ed. Artmed : Porto Alegre; 200Perusse R, Goulet JP, Turcotte JY: Contraindications to vasoconstrictors in dentistry: Part II. Oral Surg Oral Med Oral Pathol. 1992; 74: 687-91.

Perusse R, Goulet JP, Turcotte JY: Contraindications to vasoconstrictors in dentistry: Part II. Oral Surg Oral Med Oral Pathol. 1992; 74: 687-91.

Bar-Oz B, Clementi M, Giantonio E, Greenberg R, Beer M, Merlob P, et al. Metamizol (dypirone, optalgin) in pregnancy, is it safe? A prospective study. Eur J Obstet Gynecol Reprod Biol. 2005; 119: 176-9.

Benseñor IM. To use or not to use dipyrone? Or maybe, central station versus ER? That is the question. São Paulo Med J 2001; 119: 190-1.

Hedenmalm K, Spigset O. Agranulocytosis and other blood dyscrasias associated with dipyrone (metamizole). Eur J Clin Pharmacol. 2002; 58: 265-74.

Andrade SE. Comparative safety evaluation of non-narcotic analgesics. J Clin Epidemiol. 1998; 51: 1357-65.

International Agranulocytosis and Aplastic Anemia Study (The Boston Study). Risks of agranulocytosis and aplastic anemia. A first report of their relation to drug use with reference to analgesics. J Am Med Assoc. 1986; 256: 1749-57.

Ibanez L, Vidal X, Ballarin E, Laporte JR. Agranulocytosis associated with dipyrone (metamizol). Eur J Clin Pharmacol. 2005; 60: 821-9.

Painel internacional de avaliação da segurança da dipirona. 2001 Jul 3-4; Brasília; 2001.Disponível em: http://www.anvisa.gov.br/ divulga/alertas.

Szczklik A. Analgesics, allergy and asthma. Drugs. 1986; 32: 148-63.

Levy S, Volans G. The use of analgesics in patients with asthma. Drug Saf. 2001; 24: 829-41.

The Brazilian Journal of Oral Sciences uses the Creative Commons license (CC), thus preserving the integrity of the articles in an open access environment.

Downloads

Download data is not yet available.